The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...

Three independent pharmacies have filed lawsuits accusing GoodRx, which markets a prescription drug discount card, of ...

The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

Market Leadership in Pharmacy Benefit Management: The Cigna Group's merger with Express Scripts in 2018 significantly bolstered its pharmacy benefit management (PBM) and specialty pharmacy services.

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Combining with Express Scripts gave Cigna more tools to help clients control their healthcare costs, and we see significant cross-selling opportunities across their respective books of business. Cigna ...

Cigna surpassed quarterly profit estimates on Thursday, driven by strong demand for its specialty drugs and new clients for ...

The Cigna Group reported $739 million in profit for the third quarter, a figure that accounts for a $1 billion after-tax ...

Cigna surpassed Wall Street estimates for third-quarter profit on Thursday, driven by high demand for biosimilars of a ...